SOBI — Swedish Orphan Biovitrum AB (publ) Cashflow Statement
0.000.00%
Last trade - 00:00- SEK95.34bn
- SEK110.94bn
- SEK26.03bn
- 98
- 25
- 51
- 62
Annual cashflow statement for Swedish Orphan Biovitrum AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
C2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Interim Report | ARS | Interim Report | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 4,217 | 3,295 | 3,321 | 2,954 | 4,407 |
| Depreciation | |||||
| Non-Cash Items | 46 | 503 | 316 | 1,040 | 845 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1,360 | -334 | -1,480 | -2,724 | -1,543 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 4,926 | 5,470 | 4,576 | 4,470 | 7,388 |
| Capital Expenditures | -3,852 | -370 | -1,477 | -4,943 | -3,005 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -112 | 3 | — | -16,961 | -86 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -3,964 | -367 | -1,477 | -21,904 | -3,091 |
| Financing Cash Flow Items | 288 | -351 | -438 | -203 | 178 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1,282 | -4,474 | -2,902 | 17,012 | -4,001 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -333 | 641 | 316 | -457 | 235 |